| Serial Number | 97881861 |
| Word Mark | ENCAPSULATING THE FUTURE |
| Filing Date | Monday, April 10, 2023 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Thursday, October 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome Formulation, Manufacturing, and Analytical Services; Product development for others; Product research and development; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Performance of chemical analyses; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing medical and scientific research information in the field of pharmaceuticals; Providing reagent sample testing and diagnostic services for others for scientific research purposes |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 4, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, February 13, 2024 |
| First Use In Commerce Date | Tuesday, February 13, 2024 |
| Party Name | Helix Biotech, Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Knoxville, TN 37918 |
| Party Name | Helix Biotech, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Knoxville, TN 37918 |
| Event Date | Event Description |
| Thursday, May 4, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 13, 2023 | NEW APPLICATION ENTERED |
| Friday, November 10, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, January 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, January 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, January 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, August 13, 2024 | USE AMENDMENT FILED |
| Tuesday, August 13, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, October 17, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, October 17, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, October 24, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Thursday, October 24, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |